Phibro Animal Health Corporation logo

Phibro Animal Health Corporation (PAHC)

Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS)
$
38. 82
+0.84
+2.2117%
$
1.55B Market Cap
35.95 P/E Ratio
0.48% Div Yield
187,000 Volume
1.1 Eps
$ 37.98
Previous Close
Add Transaction
Day Range
37.24 38.94
Year Range
28.25 60.08
Want to track PAHC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term

Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
PAHC vs. BSX: Which Stock Is the Better Value Option?

PAHC vs. BSX: Which Stock Is the Better Value Option?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks | 1 year ago
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?

Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
Should You Bet on PAHC Stock at a Discounted P/E of 10.41X?

Should You Bet on PAHC Stock at a Discounted P/E of 10.41X?

PAHC's solid MFA franchise, now bolstered by Zoetis' portfolio, makes it a solid investment case. A well-established foothold in key regions is also a factor.

Zacks | 1 year ago
Looking for a Growth Stock? 3 Reasons Why Phibro (PAHC) is a Solid Choice

Looking for a Growth Stock? 3 Reasons Why Phibro (PAHC) is a Solid Choice

Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.

Zacks | 1 year ago
PAHC vs. BSX: Which Stock Should Value Investors Buy Now?

PAHC vs. BSX: Which Stock Should Value Investors Buy Now?

Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks | 1 year ago
Is Phibro Animal Health (PAHC) a Great Value Stock Right Now?

Is Phibro Animal Health (PAHC) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 1 year ago
Phibro Animal Health Stock Up 87.5% in a Year: What's Driving the Rise?

Phibro Animal Health Stock Up 87.5% in a Year: What's Driving the Rise?

PAHC stays on investors' radar due to its Animal Health business and potential in emerging markets.

Zacks | 1 year ago
Why Is Phibro (PAHC) Down 5.2% Since Last Earnings Report?

Why Is Phibro (PAHC) Down 5.2% Since Last Earnings Report?

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 year ago
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock

Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 year ago
Is PAHC Stock a Smart Addition to Your Portfolio Right Now?

Is PAHC Stock a Smart Addition to Your Portfolio Right Now?

Phibro's robust performance in the Animal Health business and prospects in the emerging markets are highly encouraging.

Zacks | 1 year ago
3 Reasons Why Growth Investors Shouldn't Overlook Phibro (PAHC)

3 Reasons Why Growth Investors Shouldn't Overlook Phibro (PAHC)

Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.

Zacks | 1 year ago
Loading...
Load More